TY - JOUR
T1 - Acute Dietary Nitrate Intake Improves Muscle Contractile Function in Patients with Heart Failure
T2 - A Double-Blind, Placebo-Controlled, Randomized Trial
AU - Coggan, Andrew R.
AU - Leibowitz, Joshua L.
AU - Spearie, Catherine Anderson
AU - Kadkhodayan, Ana
AU - Thomas, Deepak P.
AU - Ramamurthy, Sujata
AU - Mahmood, Kiran
AU - Park, Soo
AU - Waller, Suzanne
AU - Farmer, Marsha
AU - Peterson, Linda R.
N1 - Publisher Copyright:
© 2015 American Heart Association, Inc.
PY - 2015/9/1
Y1 - 2015/9/1
N2 - Skeletal muscle strength, velocity, and power are markedly reduced in patients with heart failure, which contributes to their impaired exercise capacity and lower quality of life. This muscle dysfunction may be partially because of decreased nitric oxide (NO) bioavailability. We therefore sought to determine whether ingestion of inorganic nitrate (NO3-) would increase NO production and improve muscle function in patients with heart failure because of systolic dysfunction. Methods and Results-Using a double-blind, placebo-controlled, randomized crossover design, we determined the effects of dietary NO3- in 9 patients with heart failure. After fasting overnight, subjects drank beetroot juice containing or devoid of 11.2 mmol of NO3-. Two hours later, muscle function was assessed using isokinetic dynamometry. Dietary NO3- increased (P<0.05-0.001) breath NO by 35% to 50%. This was accompanied by 9% (P=0.07) and 11% (P<0.05) increases in peak knee extensor power at the 2 highest movement velocities tested (ie, 4.71 and 6.28 rad/s). Maximal power (calculated by fitting peak power data with a parabola) was therefore greater (ie, 4.74±0.41 versus 4.20±0.33 W/kg; P<0.05) after dietary NO3- intake. Calculated maximal velocity of knee extension was also higher after NO3- ingestion (ie, 12.48±0.95 versus 11.11±0.53 rad/s; P<0.05). Blood pressure was unchanged, and no adverse clinical events occurred. Conclusions-In this pilot study, acute dietary NO3- intake was well tolerated and enhanced NO bioavailability and muscle power in patients with systolic heart failure. Larger-scale studies should be conducted to determine whether the latter translates into an improved quality of life in this population.
AB - Skeletal muscle strength, velocity, and power are markedly reduced in patients with heart failure, which contributes to their impaired exercise capacity and lower quality of life. This muscle dysfunction may be partially because of decreased nitric oxide (NO) bioavailability. We therefore sought to determine whether ingestion of inorganic nitrate (NO3-) would increase NO production and improve muscle function in patients with heart failure because of systolic dysfunction. Methods and Results-Using a double-blind, placebo-controlled, randomized crossover design, we determined the effects of dietary NO3- in 9 patients with heart failure. After fasting overnight, subjects drank beetroot juice containing or devoid of 11.2 mmol of NO3-. Two hours later, muscle function was assessed using isokinetic dynamometry. Dietary NO3- increased (P<0.05-0.001) breath NO by 35% to 50%. This was accompanied by 9% (P=0.07) and 11% (P<0.05) increases in peak knee extensor power at the 2 highest movement velocities tested (ie, 4.71 and 6.28 rad/s). Maximal power (calculated by fitting peak power data with a parabola) was therefore greater (ie, 4.74±0.41 versus 4.20±0.33 W/kg; P<0.05) after dietary NO3- intake. Calculated maximal velocity of knee extension was also higher after NO3- ingestion (ie, 12.48±0.95 versus 11.11±0.53 rad/s; P<0.05). Blood pressure was unchanged, and no adverse clinical events occurred. Conclusions-In this pilot study, acute dietary NO3- intake was well tolerated and enhanced NO bioavailability and muscle power in patients with systolic heart failure. Larger-scale studies should be conducted to determine whether the latter translates into an improved quality of life in this population.
KW - Heart failure
KW - muscle contraction
KW - muscle strength
KW - nitrates
KW - nitric oxide
KW - nutrition theory
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=84957652781&partnerID=8YFLogxK
U2 - 10.1161/CIRCHEARTFAILURE.115.002141
DO - 10.1161/CIRCHEARTFAILURE.115.002141
M3 - Article
C2 - 26179185
AN - SCOPUS:84957652781
SN - 1941-3289
VL - 8
SP - 914
EP - 920
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
IS - 5
ER -